Results 11 to 20 of about 25,164 (313)

Pharmacological profile of prescriptions containing antidepressants

open access: yesJournal of Marine Medical Society, 2021
Background: The prescription of antidepressants is increasing due to the increasing incidence of depression and the use of antidepressants in other indications.
Prafull Mohan   +3 more
doaj   +1 more source

Acute dystonia with concomitant use of amitriptyline and paroxetine

open access: yesOpen Journal of Psychiatry and Allied Sciences, 2017
Amitriptyline and paroxetine are antidepressant agents useful for the treatment depressive disorders. Antidepressant induced extrapyramidal symptoms represent an under recognised but important clinical entity as it can adversely impact treatment ...
Sachin Ratan Gedam   +2 more
doaj   +1 more source

What mechanisms are responsible for the reuptake of levodopa-derived dopamine in parkinsonian striatum?

open access: yesFrontiers in Neuroscience, 2016
Levodopa is the most effective medication for motor symptoms in Parkinson’s disease. However, various motor and non-motor complications are associated with levodopa treatment, resulting from altered levodopa-dopamine metabolism with disease progression ...
Haruo Nishijima   +3 more
doaj   +1 more source

Review of a New Multimodal Antidepressant Vortioxetine

open access: yesActa Medica Martiniana, 2016
Vortioxetine is a novel antidepressant with two mechanisms of action – direct effect on several serotonin receptors and serotonin re-uptake inhibition.
Oppa M   +3 more
doaj   +1 more source

Fluoxetine-induced blurring of vision: a rare ocular side effect

open access: yesOpen Journal of Psychiatry and Allied Sciences, 2017
A young male presented with second episode of depressive symptoms of one month duration; treatment started with fluoxetine and on third week of starting of treatment, he developed sudden onset blurring of vision due to mydriasis which dramatically ...
Namita Deka, Roopam Kumari
doaj   +1 more source

Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment

open access: yesActa Medica Bulgarica, 2020
Background: Data on the clinical characteristics of premenstrual syndrome (PMS) with co-morbid major depressive disorder (MDD) are scarce. Although selective serotonin re-uptake inhibitors (SSRIs) are widely used to treat both PMS and MDD there is little
Yakimova R.   +4 more
doaj   +1 more source

The use of LeuT as a receptor model for antidepressant development

open access: yesHealth Science Journal of Indonesia, 2012
Selective serotonin re-uptake inhibitors (SSRIs) merupakan golongan antidepresan yang cukup selektif terhadap serotonin re-uptake transporter (SERT). Sertraline dan fluoxetine merupakan golongan SSRI yang mempunyai afinitas kuat terhadap SERT serta mampu
Lina Rustanti
doaj   +3 more sources

Selective Serotonin Re-uptake Inhibitors: An Overview

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Over the past decade there has been a crescendo of interest in the role of the serotonin system in mediating both anxiety and depressive disorders. Researchs has provided therapeutic compounds that are selective for re-uptake blockade in the serotonin ...
İsmail ÇİFTER
doaj  

Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: A 2-Year Prospective Observational Study

open access: yesSexual Medicine, 2017
Introduction: Although dapoxetine is the only oral pharmacologic agent approved for the treatment of premature ejaculation (PE) and is very effective, the discontinuation rate is high.
Hyun Jun Park, MD, PhD   +5 more
doaj   +1 more source

Additive Antidepressant Effects of Combined Administration of Ecitalopram and Caloric Restriction in LPS-Induced Neonatal Model of Depression in Rats

open access: yesActa Medica Bulgarica, 2020
Background and aims: Increasing evidence indicates that inflammation in the periphery and neuroinflammation in the brain might be involved in the pathophysiology of depressive symptoms in humans.
Haritov E., Tivcheva J.
doaj   +1 more source

Home - About - Disclaimer - Privacy